Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Hypericum polyanthemum cyclohexane extract potentiates behavioral effects and neurodegeneration induced by nigral infusions of 6-hydroxydopamine in rats.

Borsoi M, Batassini C, Lazzaretti C, Silvestrin RB, Betti AH, Stein AC, von Poser GL, Rates SMK, Souza TME.

Neurosci Lett. 2018 Nov 20;687:177-182. doi: 10.1016/j.neulet.2018.09.048. Epub 2018 Sep 25.

PMID:
30266672
2.

[Overdosing of pipamperone from a squeeze bottle].

de Roo JHC, Bosch TM, van Rhijn A, Del Canho R.

Ned Tijdschr Geneeskd. 2018;162:D2160. Dutch.

PMID:
29543144
3.

Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats.

Motaghinejad M, Motevalian M, Fatima S, Beiranvand T, Mozaffari S.

J Neural Transm (Vienna). 2017 Nov;124(11):1369-1387. doi: 10.1007/s00702-017-1771-2. Epub 2017 Aug 9.

PMID:
28795276
4.

Motor deficits, impaired response inhibition, and blunted response to methylphenidate following neonatal exposure to decabromodiphenyl ether.

Markowski VP, Miller-Rhodes P, Cheung R, Goeke C, Pecoraro V, Cohen G, Small DJ.

Neurotoxicol Teratol. 2017 Sep;63:51-59. doi: 10.1016/j.ntt.2017.07.003. Epub 2017 Jul 29.

5.

Methamphetamine-Related Disorders.

Gouzoulis-Mayfrank E, Härtel-Petri R, Hamdorf W, Havemann-Reinecke U, Mühlig S, Wodarz N.

Dtsch Arztebl Int. 2017 Jun 30;114(26):455-461. doi: 10.3238/arztebl.2017.0455.

6.

A Case of Nonfatal Intoxication Associated with the Recreational use of Diphenidine.

Gerace E, Bovetto E, Corcia DD, Vincenti M, Salomone A.

J Forensic Sci. 2017 Jul;62(4):1107-1111. doi: 10.1111/1556-4029.13355. Epub 2017 Jun 9.

PMID:
28597920
7.

Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences.

Motaghinejad M, Motevalian M, Babalouei F, Abdollahi M, Heidari M, Madjd Z.

Brain Res Bull. 2017 Jun;132:82-98. doi: 10.1016/j.brainresbull.2017.05.011. Epub 2017 May 24.

PMID:
28552672
8.

Methylphenidate effects in the young brain: friend or foe?

Loureiro-Vieira S, Costa VM, de Lourdes Bastos M, Carvalho F, Capela JP.

Int J Dev Neurosci. 2017 Aug;60:34-47. doi: 10.1016/j.ijdevneu.2017.04.002. Epub 2017 Apr 13. Review.

PMID:
28412445
9.

Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.

Feio-Azevedo R, Costa VM, Ferreira LM, Branco PS, Pereira FC, Bastos ML, Carvalho F, Capela JP.

Toxicol Lett. 2017 Mar 5;269:65-76. doi: 10.1016/j.toxlet.2017.01.012. Epub 2017 Jan 20.

PMID:
28115274
10.

Mediatory role of NMDA, AMPA/kainate, GABAA and Alpha2 receptors in topiramate neuroprotective effects against methylphenidate induced neurotoxicity in rat.

Motaghinejad M, Motevalian M, Fatima S.

Life Sci. 2017 Jun 15;179:37-53. doi: 10.1016/j.lfs.2017.01.002. Epub 2017 Jan 10.

PMID:
28082019
11.

Citalopram-induced dyskinesia of the tongue: a video presentation.

Gaanderse M, Kliffen J, Linssen W.

BMJ Case Rep. 2016 Dec 23;2016. pii: bcr2016216126. doi: 10.1136/bcr-2016-216126.

12.

[Acute psychiatric symptoms during methylphenidate intravenous injections: A case report].

Vérité F, Micallef J.

Therapie. 2017 Jun;72(3):367-372. doi: 10.1016/j.therap.2016.10.002. Epub 2016 Nov 24. French.

PMID:
27988038
13.

Drugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic?

Kakish J, Lee D, Lee JS.

ACS Chem Neurosci. 2015 Dec 16;6(12):1930-40. doi: 10.1021/acschemneuro.5b00172. Epub 2015 Sep 28. Review.

PMID:
26378986
14.

Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.

Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D.

Neuroimage. 2015 Nov 1;121:20-8. doi: 10.1016/j.neuroimage.2015.07.035. Epub 2015 Jul 21.

PMID:
26208874
15.

Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings.

Bottelier MA, Schouw ML, de Ruiter MB, Ruhe HG, Lindauer RJ, Reneman L.

Brain Imaging Behav. 2015 Dec;9(4):878-86. doi: 10.1007/s11682-014-9350-8.

PMID:
25563230
16.
17.

Adult onset methylphenidate induced dyskinesia after stroke.

Kim JY, Baik JS.

Parkinsonism Relat Disord. 2014 Jul;20(7):789-91. doi: 10.1016/j.parkreldis.2014.03.021. Epub 2014 Apr 1. No abstract available.

PMID:
24731527
18.

Nucleus accumbens neuronal activity correlates to the animal's behavioral response to acute and chronic methylphenidate.

Claussen CM, Chong SL, Dafny N.

Physiol Behav. 2014 Apr 22;129:85-94. doi: 10.1016/j.physbeh.2014.02.024. Epub 2014 Feb 15.

19.

Non-dopaminergic treatments for motor control in Parkinson's disease.

Fox SH.

Drugs. 2013 Sep;73(13):1405-15. doi: 10.1007/s40265-013-0105-4. Review. Erratum in: Drugs. 2014 Jul;74(11):1305.

PMID:
23917951
20.

Acute dyskinetic reaction in a healthy toddler following methylphenidate ingestion.

Waugh JL.

Pediatr Neurol. 2013 Jul;49(1):58-60. doi: 10.1016/j.pediatrneurol.2013.01.008. Epub 2013 May 16.

PMID:
23683540

Supplemental Content

Loading ...
Support Center